Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Finasteride Does Not Increase Risk for High-Grade Prostate Cancer
Link ID 17179
Title Finasteride Does Not Increase Risk for High-Grade Prostate Cancer
Url http://www.medscape.com/viewarticle/705804?src=rss
Description Decreases in prostate volume over time and resulting changes in PSA performance may have contributed to the detection of high-grade prostate cancer in the finasteride group of the PCPT. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Jul 14, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Chemotherapy Foundation Symposium 2008
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. Musculoskeletal Syndromes Associated With Malignancy (Excluding Hypertrophic Osteoarthropathy)
  This article reviews the recent data supporting the association between rheumatic disorders and cancer. Current Opinion in Rheumatology
Category:   Articles > Hematology-Oncology


3. Risk for False-Positive Lung Cancer Screening is Substantial
  Lung cancer screening has theoretical but unproven benefits and substantial proven harms. Journal Watch
Category:   Articles > Hematology-Oncology


4. Strategy for Incorporating Molecular and Cytogenetic Markers into Acute Myeloid Leukemia Therapy
  Acute myeloid leukemia is a challenging disease to treat, but new molecular and cytogenetic markers can help clinicians guide patients to more effective and safe therapy. The current article reviews these markers and offers strategies for their clinical application. Journal of the National Comprehensive Cancer Network
Category:   Articles > Hematology-Oncology


5. Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analys
  Short-term results are favorable for the dose-intense regimen, but do they last? Journal of the National Cancer Institute
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS